How do CARs work?: Early insights from recent clinical studies targeting CD19

Second-generation chimeric antigen receptors (CARs) are powerful tools to redirect antigen-specific T cells independently of HLA-restriction. Recent clinical studies evaluating CD19-targeted T cells in patients with B-cell malignancies demonstrate the potency of CAR-engineered T cells. With results...

Descripción completa

Detalles Bibliográficos
Autores principales: Davila, Marco L., Brentjens, Renier, Wang, Xiuyan, Rivière, Isabelle, Sadelain, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525612/
https://www.ncbi.nlm.nih.gov/pubmed/23264903
http://dx.doi.org/10.4161/onci.22524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525612/
https://www.ncbi.nlm.nih.gov/pubmed/23264903
http://dx.doi.org/10.4161/onci.22524

Ejemplares similares